




Eurepa-V 1/0.2 Tablet
Manufacturer
Torrent Pharmaceuticals Ltd
Salt Composition
Repaglinide (1mg) + Voglibose (0.2mg)
Key Information
Short Description
Eurepa-V 1/0.2 Tablet is a combination of two medicines used to treat type 2 diabetes mellitus, controlling high blood sugar levels after each meal.
Dosage Form
Tablet
Introduction
Eurepa-V 1/0.2 Tablet is a combination of two medicines used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Eurepa-V 1/0.2 Tablet is to be taken with food.
Safety Information
Side Effects
No common side effects listed.
How it works
Eurepa-V 1/0.2 Tablet is a combination of two antidiabetic medicines:
Quick Tips
Eurepa-V 1/0.2 Tablet is a combination medicine that can control blood sugar better than either medicine alone. Exercise eat a healthy diet and take your other diabetes medicines along with Eurepa-V 1/0.2 Tablet. Take it around 15 minutes before a main meal. It can cause hypoglycemia (low blood sugar level) with other antidiabetic medicines, alcohol, or if you delay a meal. Check your blood sugar regularly. Always carry some sugary food to manage hypoglycemia symptoms (cold sweats, pale skin, tremors, and anxiety).
Related Medicines

Volibo R 0.2mg/1mg Tablet

Volix-R 0.2/1 Tablet

Vogli-Rapid 0.2/1 Tablet

Trubogli Forte 1mg/0.2mg Tablet

Mega V 1mg/0.2mg Tablet

Vobit R 1mg/0.2mg Tablet

Mage V 1mg/0.2mg Tablet

Voglimac R 1mg/0.2mg Tablet

Volga R 1mg/0.2mg Tablet
